UPTquik® NT-proBNP Kit
- FOB Price:Get Latest Price >
- Min.Order:10 Box(es)
- Payment Terms:L/C , T/T , D/P , Others
- Favorite
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
Beijing Hotgen Biotech Co.,Ltd.
We are professional supplier of UPTquik® System,ELISA Kits,Chemiluminescence,Q-tube®AFP-L3,UPT test® Biodefense,UPT test® Food Safety.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
UPTquik® NT-proBNP Kit
Full name: N-terminal pro B-type natriuretic peptide
UPTquik® NT-proBNP is an accurate, rapid, fully quantitative test used on UPTquik® Reader for the determination of the N-terminal fragment of brain-type natriuretic peptide in human serum, plasma and whole blood as an aiding tool for screening, diagnosis and risk assessment of life-threatening heart failure (HF).
NT-proBNP: A proven biomarker for heart failure
The N-terminal pro B-type natriuretic peptide (NT-proBNP) is a 76 amino acid N-terminal inactive protein that is cleaved from proBNP to release brain natriuretic peptide.
The plasma concentrations of both BNP and NT-proBNP are typically increased in patients with asymptomatic or symptomatic left ventricular dysfunction and is associated with coronary artery disease and myocardial ischemia. As the latter is more stable and has higher concentration and a longer shelf life in blood, NT-proBNP is a much better biomarker and used much more often.
Early diagnosis of heart failure is key to improve patient outcome. Using NT-proBNP can help clinicians optimize management of patients with dyspnea in the emergency room. This has shown to result in significant cost savings for healthcare structures due to shorter stays in the emergency department and reduced patient re-hospitalization.
International guidelines recommend the use of B-type natriuretic peptide testing in the diagnostic workup of Heart Failure (HF) in both acute and non-acute patient presentation.
Benefits of NT-proBNP test in summary:
- Diagnosis of patients with suspected CHF
- Risk stratification of patients with HF
- Risk stratification of patients with ACS
- Assessment of increased risk for cardiovascular events and mortality in patients at risk for HF who have stable coronary artery disease (CAD)
UPTquik® NT-proBNP Kit Test Principle
Up-converting Phosphor Technology
UPTquik® NT-proBNP Kit Features
- Fully quantitative NT-proBNP measurement
- Rapid, accurate, lab quality results within minutes
- Ready-to-use reagents
- Serum, plasma and whole blood are applicable as sample
- Long shelf life
- Easy storage at room temperature
- Single dose format: run only the test you need